Details for New Drug Application (NDA): 018664
✉ Email this page to a colleague
NDA 018664 describes IOSAT, which is a drug marketed by Anbex and is included in one NDA. It is available from one supplier. Additional details are available on the IOSAT profile page.
The generic ingredient in IOSAT is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
The generic ingredient in IOSAT is potassium iodide. There are two hundred and forty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium iodide profile page.
Summary for 018664
| Tradename: | IOSAT |
| Applicant: | Anbex |
| Ingredient: | potassium iodide |
| Patents: | 0 |
Suppliers and Packaging for NDA: 018664
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| IOSAT | potassium iodide | TABLET;ORAL | 018664 | NDA | Anbex Inc. | 51803-001 | 51803-001-01 | 14 TABLET in 1 PACKAGE (51803-001-01) |
| IOSAT | potassium iodide | TABLET;ORAL | 018664 | NDA | Anbex Inc. | 51803-001 | 51803-001-10 | 10 PACKAGE in 1 BAG (51803-001-10) / 14 TABLET in 1 PACKAGE (51803-001-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 130MG | ||||
| Approval Date: | Oct 14, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 65MG | ||||
| Approval Date: | May 12, 2011 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
